title: Pregabalin suppresses spinal neuronal hyperexcitability and visceral hypersensitivity in the absence of peripheral pathophysiology.
abstract: BACKGROUND
  Opioid-induced hyperalgesia is recognized in the laboratory and the clinic, generating central hyperexcitability in the absence of peripheral pathology. We investigated pregabalin, indicated for neuropathic pain, and ondansetron, a drug that disrupts descending serotonergic processing in the central nervous system, on spinal neuronal hyperexcitability and visceral hypersensitivity in a rat model of opioid-induced hyperalgesia.
  
  
  METHODS
  Male Sprague-Dawley rats (180-200 g) were implanted with osmotic mini-pumps filled with morphine (90 μg · μl⁻¹ · h⁻¹) or saline (0.9% w/v). On days 7-10 in isoflurane anesthetized animals, we evaluated the effects of (1) systemic pregabalin on spinal neuronal and visceromotor responses, and (2) spinal ondansetron on dorsal horn neuronal response. Messenger ribonucleic acid concentrations of α2δ-1, 5HT3A, and μ-opioid receptor in the dorsal root ganglia of all animals were analyzed.
  
  
  RESULTS
  In morphine-treated animals, evoked spinal neuronal responses were enhanced to a subset of thermal and mechanical stimuli. This activity was attenuated by pregabalin (by at least 71%) and ondansetron (37%); the visceromotor response to a subset of colorectal distension pressures was attenuated by pregabalin (52.8%; n = 8 for all measures, P < 0.05). Messenger ribonucleic acid concentrations were unchanged.
  
  
  CONCLUSIONS
  The inhibitory action of pregabalin in opioid-induced hyperalgesia animals is neither neuropathy-dependent nor reliant on up-regulation of the α₂δ-1 subunit of voltage-gated calcium channels-mechanisms proposed as being essential for pregabalin's efficacy in neuropathy. In opioid-induced hyperalgesia, which extends to colonic distension, a serotonergic facilitatory system may be up-regulated, creating an environment that is permissive for pregabalin-mediated analgesia without peripheral pathology.
authors: Department of Neuroscience, Pharmacology and Physiology, University College London, London, UK. kirsty.bannister@ucl.ac.uk
authors: Kirsty
authors: K
authors: Bannister
authors: Shafaq
authors: S
authors: Sikandar
authors: Claudia S
authors: CS
authors: Bauer
authors: Annette C
authors: AC
authors: Dolphin
authors: Frank
authors: F
authors: Porreca
authors: Anthony H
authors: AH
authors: Dickenson
references: N Engl J Med. 2005 Mar 31;352(13):1324-34
references: 15800228
references: Neurosci Lett. 2009 Oct 2;462(1):68-72
references: 19559072
references: Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18195-200
references: 16330766
references: Gut. 2007 Oct;56(10):1482-4
references: 17872585
references: Anesthesiology. 2006 Mar;104(3):570-87
references: 16508405
references: Acta Anaesthesiol Scand. 1988 Apr;32(3):253-9
references: 3364150
references: J Pain. 2006 Jan;7(1):43-8
references: 16414554
references: J Neurosci. 2009 Apr 1;29(13):4076-88
references: 19339603
references: Pain. 2003 Dec;106(3):347-356
references: 14659517
references: J Neurosci. 1995 Mar;15(3 Pt 2):2396-406
references: 7891175
references: Br J Pharmacol. 2006 Nov;149(5):498-505
references: 16921395
references: Ann N Y Acad Sci. 2001 Mar;933:175-84
references: 12000019
references: Expert Opin Emerg Drugs. 2010 Sep;15(3):521-33
references: 20486862
references: Pain. 2007 May;129(1-2):35-45
references: 17123731
references: Pain. 2008 Nov 15;140(1):209-223
references: 18809257
references: Neurosignals. 2005;14(4):194-205
references: 16215302
references: Pain. 2005 Aug;116(3):276-288
references: 15964684
references: Br J Anaesth. 2008 Jul;101(1):8-16
references: 18417503
references: J Pharmacol Exp Ther. 2000 Oct;295(1):162-7
references: 10991974
references: Anesthesiology. 2000 Aug;93(2):409-17
references: 10910490
references: Am J Ther. 2010 Jul-Aug;17(4):418-39
references: 20562596
references: Nat Neurosci. 2002 Dec;5(12):1319-26
references: 12402039
references: Spine (Phila Pa 1976). 2002 Jul 15;27(14):1517-24; discussion 1525
references: 12131710
references: Neurosci Lett. 2006 Oct 23;407(2):156-61
references: 16959420
references: Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17537-42
references: 17088553
references: Neurosci Lett. 1996 Apr 26;208(3):203-7
references: 8733305
references: Pain. 2005 Oct;117(3):292-303
references: 16150546
references: J Neurosci. 1994 Apr;14(4):2301-12
references: 7908958
references: Neuroreport. 1997 Feb 10;8(3):587-90
references: 9106728
references: J Neurosci. 2002 Aug 1;22(15):6747-55
references: 12151554
references: Pain. 2001 May;92(1-2):5-9
references: 11323121
references: Anesthesiology. 2008 Mar;108(3):484-94
references: 18292686
references: J Pain. 2009 Mar;10(3):316-22
references: 19101210
references: Eur J Neurosci. 2009 Feb;29(4):727-37
references: 19200067
references: Br J Pharmacol. 2000 Sep;131(2):282-6
references: 10991921
references: J Neurosci. 2005 Apr 6;25(14):3551-9
references: 15814785
references: Ann Neurol. 2003 Mar;53(3):366-75
references: 12601704
references: Neurosignals. 2005;14(4):175-81
references: 16215300
references: J Neurosci. 2000 Sep 15;20(18):7074-9
references: 10995854
references: J Neurosci. 2006 Nov 29;26(48):12576-86
references: 17135419
references: Anesthesiology. 2008 Dec;109(6):1077-84
references: 19034104
references: Brain Res Mol Brain Res. 2001 Jan 31;86(1-2):56-62
references: 11165371
references: Anesthesiology. 2002 Mar;96(3):633-40
references: 11873039
references: J Neurosci. 2001 Jan 1;21(1):279-86
references: 11150345
references: J Physiol. 1999 Aug 1;518 ( Pt 3):803-13
references: 10420016
references: J Pharmacol Exp Ther. 2004 Apr;309(1):380-7
references: 14718584
references: Neurosci Res. 1996 Jun;25(2):129-35
references: 8829149
references: Br J Pharmacol. 2008 Oct;155(3):407-16
references: 18574457
references: Biol Pharm Bull. 2009 Apr;32(4):732-4
references: 19336915